<?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.2 20190208//EN?>
<?DTDIdentifier.IdentifierType public?>
<?SourceDTD.DTDName JATS-journalpublishing1.dtd?>
<?SourceDTD.Version 1.2?>
<?ConverterInfo.XSLTName jats2jats3.xsl?>
<?ConverterInfo.Version 1?>
<?properties open_access?>
<processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats">
  <restricted-by>pmc</restricted-by>
</processing-meta>
<front>
  <journal-meta>
    <journal-id journal-id-type="nlm-ta">Bioinformatics</journal-id>
    <journal-id journal-id-type="iso-abbrev">Bioinformatics</journal-id>
    <journal-id journal-id-type="publisher-id">bioinformatics</journal-id>
    <journal-title-group>
      <journal-title>Bioinformatics</journal-title>
    </journal-title-group>
    <issn pub-type="ppub">1367-4803</issn>
    <issn pub-type="epub">1367-4811</issn>
    <publisher>
      <publisher-name>Oxford University Press</publisher-name>
    </publisher>
  </journal-meta>
  <article-meta>
    <article-id pub-id-type="pmcid">9750117</article-id>
    <article-id pub-id-type="pmid">36355565</article-id>
    <article-id pub-id-type="doi">10.1093/bioinformatics/btac680</article-id>
    <article-id pub-id-type="publisher-id">btac680</article-id>
    <article-categories>
      <subj-group subj-group-type="heading">
        <subject>Applications Note</subject>
        <subj-group subj-group-type="category-toc-heading">
          <subject>Structural Bioinformatics</subject>
        </subj-group>
      </subj-group>
      <subj-group subj-group-type="category-taxonomy-collection">
        <subject>AcademicSubjects/SCI01060</subject>
      </subj-group>
    </article-categories>
    <title-group>
      <article-title>DREAMM: a web-based server for drugging protein-membrane interfaces as a novel workflow for targeted drug design</article-title>
    </title-group>
    <contrib-group>
      <contrib contrib-type="author">
        <contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0001-5891-8154</contrib-id>
        <name>
          <surname>Chatzigoulas</surname>
          <given-names>Alexios</given-names>
        </name>
        <aff><institution>Biomedical Research Foundation, Academy of Athens</institution>, Athens 11527, <country country="GR">Greece</country></aff>
        <aff><institution>Department of Informatics and Telecommunications, National and Kapodistrian University of Athens</institution>, Athens 15784, <country country="GR">Greece</country></aff>
      </contrib>
      <contrib contrib-type="author" corresp="yes">
        <name>
          <surname>Cournia</surname>
          <given-names>Zoe</given-names>
        </name>
        <aff><institution>Biomedical Research Foundation, Academy of Athens</institution>, Athens 11527, <country country="GR">Greece</country></aff>
        <aff><institution>Department of Informatics and Telecommunications, National and Kapodistrian University of Athens</institution>, Athens 15784, <country country="GR">Greece</country></aff>
        <xref rid="btac680-cor1" ref-type="corresp"/>
        <!--zcournia@bioacademy.gr-->
      </contrib>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name>
          <surname>Cowen</surname>
          <given-names>Lenore</given-names>
        </name>
        <role>Associate Editor</role>
      </contrib>
    </contrib-group>
    <author-notes>
      <corresp id="btac680-cor1">To whom correspondence should be addressed. Email: <email>zcournia@bioacademy.gr</email></corresp>
    </author-notes>
    <pub-date pub-type="collection">
      <day>15</day>
      <month>12</month>
      <year>2022</year>
    </pub-date>
    <pub-date pub-type="epub" iso-8601-date="2022-11-10">
      <day>10</day>
      <month>11</month>
      <year>2022</year>
    </pub-date>
    <pub-date pub-type="pmc-release">
      <day>10</day>
      <month>11</month>
      <year>2022</year>
    </pub-date>
    <volume>38</volume>
    <issue>24</issue>
    <fpage>5449</fpage>
    <lpage>5451</lpage>
    <history>
      <date date-type="received">
        <day>06</day>
        <month>5</month>
        <year>2022</year>
      </date>
      <date date-type="rev-recd">
        <day>20</day>
        <month>9</month>
        <year>2022</year>
      </date>
      <date date-type="editorial-decision">
        <day>10</day>
        <month>10</month>
        <year>2022</year>
      </date>
      <date date-type="accepted">
        <day>08</day>
        <month>11</month>
        <year>2022</year>
      </date>
      <date date-type="corrected-typeset">
        <day>05</day>
        <month>12</month>
        <year>2022</year>
      </date>
    </history>
    <permissions>
      <copyright-statement>© The Author(s) 2022. Published by Oxford University Press.</copyright-statement>
      <copyright-year>2022</copyright-year>
      <license>
        <ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref>
        <license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">https://creativecommons.org/licenses/by/4.0/</ext-link>), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p>
      </license>
    </permissions>
    <self-uri xlink:href="btac680.pdf"/>
    <abstract>
      <title>Abstract</title>
      <sec id="s1">
        <title>Summary</title>
        <p>The allosteric modulation of peripheral membrane proteins (PMPs) by targeting protein-membrane interactions with drug-like molecules represents a new promising therapeutic strategy for proteins currently considered undruggable. However, the accessibility of protein-membrane interfaces by small molecules has been so far unexplored, possibly due to the complexity of the interface, the limited protein-membrane structural information and the lack of computational workflows to study it. Herein, we present a pipeline for drugging protein-membrane interfaces using the DREAMM (Drugging pRotein mEmbrAne Machine learning Method) web server. DREAMM works in the back end with a fast and robust ensemble machine learning algorithm for identifying protein-membrane interfaces of PMPs. Additionally, DREAMM also identifies binding pockets in the vicinity of the predicted membrane-penetrating amino acids in protein conformational ensembles provided by the user or generated within DREAMM.</p>
      </sec>
      <sec id="s2">
        <title>Availability and implementation</title>
        <p>DREAMM web server is accessible via <ext-link xlink:href="https://dreamm.ni4os.eu" ext-link-type="uri">https://dreamm.ni4os.eu</ext-link>.</p>
      </sec>
      <sec id="s4">
        <title>Supplementary information</title>
        <p><xref rid="sup1" ref-type="supplementary-material">Supplementary data</xref> are available at <italic toggle="yes">Bioinformatics</italic> online.</p>
      </sec>
    </abstract>
    <funding-group>
      <award-group award-type="grant">
        <funding-source>
          <institution-wrap>
            <institution>State Scholarships Foundation</institution>
            <institution-id institution-id-type="DOI">10.13039/501100003447</institution-id>
          </institution-wrap>
        </funding-source>
        <award-id>MIS-5000432</award-id>
      </award-group>
      <award-group award-type="grant">
        <funding-source>
          <institution-wrap>
            <institution>Hellenic Foundation for Research and Innovation</institution>
            <institution-id institution-id-type="DOI">10.13039/501100013209</institution-id>
          </institution-wrap>
        </funding-source>
        <award-id>1780</award-id>
      </award-group>
      <award-group award-type="grant">
        <funding-source>
          <institution-wrap>
            <institution>Europe – NI4OS Europe”</institution>
          </institution-wrap>
        </funding-source>
        <award-id>857645</award-id>
      </award-group>
      <award-group award-type="grant">
        <funding-source>
          <institution-wrap>
            <institution>Greek Research &amp; Technology Network</institution>
          </institution-wrap>
        </funding-source>
      </award-group>
    </funding-group>
    <counts>
      <page-count count="3"/>
    </counts>
  </article-meta>
</front>
<body>
  <sec>
    <title>1 Introduction</title>
    <p>Peripheral membrane proteins (PMPs) have emerged as promising therapeutic targets for several diseases, such as tuberculosis and cancer (<xref rid="btac680-B3" ref-type="bibr">Boes <italic toggle="yes">et al.</italic>, 2021</xref>). Moreover, the recent patent cliff has generated an increased interest in alternative drug design strategies over the past few years, especially focusing on proteins that have been considered undruggable up to now (<xref rid="btac680-B4" ref-type="bibr">Chatzigoulas and Cournia, 2021</xref>). Drugging protein-membrane interfaces of PMPs is a new promising therapeutic strategy for orthosteric inhibition or allosteric modulation of PMPs presumed undruggable (<xref rid="btac680-B8" ref-type="bibr">Cournia and Chatzigoulas, 2020</xref>; <xref rid="btac680-B28" ref-type="bibr">Segers <italic toggle="yes">et al.</italic>, 2007</xref>; <xref rid="btac680-B30" ref-type="bibr">Spiegel <italic toggle="yes">et al.</italic>, 2004</xref>). This drug design strategy has been so far overlooked possibly due to the complexity of the interface, the limited number of protein-membrane binding structural studies, and the lack of a suitable theoretical background combined with efficient <italic toggle="yes">in silico</italic> workflows. Nevertheless, studies targeting the protein-membrane interfaces support the fact that these interfaces are druggable, and targeted drug design can be implemented for PMPs involved in deregulated cellular pathways and disease (<xref rid="btac680-B6" ref-type="bibr">Chen <italic toggle="yes">et al.</italic>, 2015</xref>; <xref rid="btac680-B17" ref-type="bibr">Li and Buck, 2020</xref>; <xref rid="btac680-B18" ref-type="bibr">Liu <italic toggle="yes">et al.</italic>, 2010</xref>; <xref rid="btac680-B22" ref-type="bibr">Nawrotek <italic toggle="yes">et al.</italic>, 2019</xref>; <xref rid="btac680-B23" ref-type="bibr">Nicolaes <italic toggle="yes">et al.</italic>, 2014</xref>; <xref rid="btac680-B28" ref-type="bibr">Segers <italic toggle="yes">et al.</italic>, 2007</xref>; <xref rid="btac680-B30" ref-type="bibr">Spiegel <italic toggle="yes">et al.</italic>, 2004</xref>).</p>
    <p>Several computational tools and web servers for predicting protein-membrane interfaces, membrane domains and lipid-binding sites have been designed in the past (<xref rid="btac680-B2" ref-type="bibr">Bhardwaj <italic toggle="yes">et al.</italic>, 2006</xref>; <xref rid="btac680-B10" ref-type="bibr">Fuglebakk and Reuter, 2018</xref>; <xref rid="btac680-B16" ref-type="bibr">Kufareva <italic toggle="yes">et al.</italic>, 2014</xref>; <xref rid="btac680-B20" ref-type="bibr">Lomize <italic toggle="yes">et al.</italic>, 2012</xref>; <xref rid="btac680-B21" ref-type="bibr">Nastou <italic toggle="yes">et al.</italic>, 2016</xref>; <xref rid="btac680-B27" ref-type="bibr">Scott <italic toggle="yes">et al.</italic>, 2006</xref>; <xref rid="btac680-B29" ref-type="bibr">Sharikov <italic toggle="yes">et al.</italic>, 2008</xref>); however, these are limited to only predicting protein-membrane interfaces and domains and they are not integrated into an efficient peripheral membrane drug discovery workflow. Herein, the protein-membrane interface prediction is followed by an automated drug design workflow that accepts as input protein conformational ensembles and then, searches for binding sites in the protein-membrane interface of each conformer (<xref rid="btac680-F1" ref-type="fig">Fig. 1</xref>). These binding sites are provided to the user to continue with docking studies for targeting the protein-membrane interface. DREAMM is offered as a free and open to all web server without login requirements which can be accessed at <ext-link xlink:href="https://dreamm.ni4os.eu" ext-link-type="uri">https://dreamm.ni4os.eu</ext-link>.</p>
    <fig position="float" id="btac680-F1">
      <label>Fig. 1.</label>
      <caption>
        <p>A schematic workflow of the DREAMM web server</p>
      </caption>
      <graphic xlink:href="btac680f1" position="float"/>
    </fig>
  </sec>
  <sec>
    <title>2 Materials and methods</title>
    <p>To predict protein-membrane interfaces, we designed a novel ensemble machine learning classifier for predicting membrane-penetrating amino acids (<xref rid="btac680-B5" ref-type="bibr">Chatzigoulas and Cournia, 2022</xref>). A summary of our ensemble classifier model is provided in the <xref rid="sup1" ref-type="supplementary-material">Supplementary information</xref>. Following the prediction of protein-membrane interfaces, DREAMM also provides the option to predict binding cavities in the vicinity of the predicted membrane-penetrating amino acids using the open-source binding site detection software P2Rank (<xref rid="btac680-B15" ref-type="bibr">Krivák and Hoksza, 2018</xref>). To account for the dynamic nature of proteins, DREAMM applies P2Rank in conformational ensembles obtained by structural biology experiments or by molecular dynamics (MD) simulations; these structures can be provided by the user. In case a conformational ensemble is unavailable, DREAMM generates protein conformations using the distance geometry-based method ExProSE (<xref rid="btac680-B11" ref-type="bibr">Greener <italic toggle="yes">et al.</italic>, 2017</xref>). Using ExProSE, DREAMM generates protein conformations using the default settings and a tolerance weighting factor (weighting of constraint tolerances for interactions) W<sub>B</sub> = 0.4. With this tolerance weighting factor value, we expect to generate structures with a small root-mean-square deviation compared to the input structure (&lt;3 Å), albeit still observing changes in the binding sites. It should be noted that ExProSE does not perform MD simulations to generate a conformational ensemble of protein configurations. A more accurate description of the conformational ensemble can be achieved using MD simulations coupled with enhanced sampling techniques such as metadynamics, replica exchange and umbrella sampling (<xref rid="btac680-B1" ref-type="bibr">Barducci <italic toggle="yes">et al.</italic>, 2011</xref>). DREAMM performs the protein-membrane interface prediction on the first structure of the provided conformational ensemble; in the case of ExProSE usage, the prediction is performed in the initial Protein Data Bank (PDB) structure. Thus, in case a conformational change is necessary to place membrane-penetrating amino acids towards the membrane, this conformation (if available) should be provided as the first structure in the ensemble because the predictions depend on structural information. In case the user uploads AlphaFold2 structures (<xref rid="btac680-B14" ref-type="bibr">Jumper <italic toggle="yes">et al.</italic>, 2021</xref>), these structure must be preprocessed to exclude low-confidence (pLDDT score &lt; 70) unstructured regions such as the N- and C-termini (for more information see the user manual). All structures of the protein conformational ensemble are then used to predict binding cavities in the vicinity of the identified membrane-penetrating amino acids as described below. Protein conformations are prepared and aligned with High-Throughput Molecular Dynamics (HTMD) Python package (<xref rid="btac680-B9" ref-type="bibr">Doerr <italic toggle="yes">et al.</italic>, 2016</xref>) and then, P2Rank predicts binding pockets in each protein conformation. DREAMM discards predicted binding pockets further than 5 Å from the closest atom of the predicted membrane-penetrating amino acids and then produces 3D visualizations of the predicted membrane-penetrating amino acids and the aforementioned binding pockets using PyMOL (<xref rid="btac680-B26" ref-type="bibr">Schrödinger, 2015</xref>) scripts generated by P2Rank. Moreover, DREAMM performs a conservation analysis of amino acid sequences to assess the conservation and diversity of the predicted binding sites (<xref rid="btac680-B54065586" ref-type="bibr">Remmert <italic toggle="yes">et al</italic>., 2012</xref>). DREAMM also evaluates the binding sites implication in large-scale protein motions using the Essential Site Scanning Analysis method (<xref rid="btac680-B19306998" ref-type="bibr">Kaynak <italic toggle="yes">et al</italic>., 2020</xref>) (for more details see the <xref rid="sup1" ref-type="supplementary-material">Supplementary information</xref>). To assist interpretation of the results, the identified binding pockets are clustered based on their center coordinates using k-means (<xref rid="btac680-B19" ref-type="bibr">Lloyd, 1982</xref>). The number of clusters, <italic toggle="yes">k</italic>, is chosen based on the Silhouette coefficient method (<xref rid="btac680-B25" ref-type="bibr">Rousseeuw, 1987</xref>) utilizing the scikit-learn Python package (<xref rid="btac680-B24" ref-type="bibr">Pedregosa <italic toggle="yes">et al.</italic>, 2011</xref>). The results of clustering are output to the user providing analyses for each binding pocket, e.g. the number of protein conformations where the binding site is found, the highest P2Rank score and the corresponding protein conformation, the mean conservation score, etc. (for more information see the ‘Download results’ and ‘Results interpretation’ section in the user manual). More information about DREAMM methodology is provided in the user manual and the <xref rid="sup1" ref-type="supplementary-material">Supplementary information</xref>.</p>
  </sec>
  <sec>
    <title>3 Web server</title>
    <p>DREAMM web server is designed with the markup and web languages HTML, CSS and JavaScript in the front end, and the PHP programming language in the back end, providing a user-friendly interface. The functionality of DREAMM is straightforward. The users input the four-letter PDB code and the chain name of the protein and hits the ‘upload’ button, or alternatively, select and upload their own PDB structure. If a user chooses to generate conformational ensembles using ExProSE, up to 50 conformations may be generated. Calculations last from a few minutes up to a few hours depending on the size of the protein. Furthermore, a queuing system runs in the background of the web server, allowing two calculations to run simultaneously and avoiding job failures due to large workload. Finally, to avoid waiting on the screen for the results, a unique URL for each job is provided, which can be bookmarked and accessed at a later time. Subsequently, the results are provided to the user, indicating which (if any) amino acids are predicted to insert into the membrane, and are visualized in the web server with JSmol (<xref rid="btac680-B13" ref-type="bibr">Hanson <italic toggle="yes">et al.</italic>, 2013</xref>). A download button allows the user to download the results including binding pocket predictions, PyMOL visualizations, and information on all binding sites at the protein-membrane interfaces of all conformations along with the clustering results. More information is provided in the user manual and the video tutorial. This service was subsequently on-boarded in the European Open Science Cloud, <ext-link xlink:href="https://dreamm.ni4os.eu/" ext-link-type="uri">https://dreamm.ni4os.eu/</ext-link>.</p>
  </sec>
  <sec>
    <title>4 Use cases</title>
    <p>The protein-membrane interface prediction function of DREAMM has been thoroughly tested as described in Refs. (<xref rid="btac680-B5" ref-type="bibr">Chatzigoulas and Cournia, 2022; </xref><xref rid="btac680-B50982314" ref-type="bibr">Jiang <italic toggle="yes">et al.</italic>, 2022</xref>; <xref rid="btac680-B6534996" ref-type="bibr">Valenstein <italic toggle="yes">et al</italic>., 2022</xref>). Moreover, DREAMM was assessed on four recently crystallized conformations of the protein FakB1, whose W180 is an important amino acid for FakB1-membrane binding (<xref rid="btac680-B12" ref-type="bibr">Gullett <italic toggle="yes">et al.</italic>, 2022</xref>). In all four conformations, DREAMM predicts W180 and adjacent amino acids as membrane penetrating (<xref rid="sup1" ref-type="supplementary-material">Supplementary Table S1</xref> and <xref rid="sup1" ref-type="supplementary-material">Supplementary Fig. S1</xref>).</p>
    <p>To test the drug design pipeline of DREAMM, the binding site prediction module of DREAMM using the ‘protein conformational ensembles’ function was applied to the nuclear magnetic resonance structure of the PH domain of ceramide transfer protein [PDB ID: 2RSG (<xref rid="btac680-B31" ref-type="bibr">Sugiki <italic toggle="yes">et al.</italic>, 2012</xref>)]. All structures were prepared and aligned with HTMD, and then, P2Rank was used within DREAMM to predict binding sites. Two putative binding sites were identified in the vicinity of the predicted membrane-penetrating amino acids W33, N35, Y36, I37, G39 and W40. After clustering the binding pockets of all different conformations, a consensus binding site emerged in 19/20 conformations and a second binding site emerged in one conformation (<xref rid="sup1" ref-type="supplementary-material">Supplementary Table S2</xref> and <xref rid="sup1" ref-type="supplementary-material">Supplementary Fig. S2</xref>). Rational drug design in the binding site with the best average P2Rank score, which is the consensus binding site, could be envisaged for modulating the ceramide transfer protein function (<xref rid="btac680-B244716" ref-type="bibr">Chung <italic toggle="yes">et al.</italic>, 2021</xref>).</p>
  </sec>
  <sec>
    <title>Funding</title>
    <p>This work was supported by the State Scholarships Foundation (ΙΚΥ) [MIS-5000432 to A.C.]; and the Hellenic Foundation for Research and Innovation (H.F.R.I.) [1780 to Z.C.]. We thank the European Union's Horizon 2020 European research infastructures, “National Initiatives for Open Science in Europe – NI4OS Europe” project (grant agrrement no. 857645) for providing us with a virtual machine, and a domain for our web server and onboarding this service to the European Open Science Cloud. We acknowledge computational time granted from the Greek Research &amp; Technology Network (GRNET) in the National HPC facility – ARIS under project IDs pr008033_gpu/Mem-Surf and pr008033_thin/Mem-Surf.</p>
    <p><italic toggle="yes">Conflict of Interest</italic>: none declared.</p>
  </sec>
  <sec sec-type="supplementary-material">
    <title>Supplementary Material</title>
    <supplementary-material id="sup1" position="float" content-type="local-data">
      <label>btac680_Supplementary_Data</label>
      <media xlink:href="btac680_supplementary_data.zip">
        <caption>
          <p>Click here for additional data file.</p>
        </caption>
      </media>
    </supplementary-material>
  </sec>
</body>
<back>
  <ref-list id="ref1">
    <title>References</title>
    <ref id="btac680-B1">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Barducci</surname><given-names>A.</given-names></string-name></person-group><etal>et al</etal> (<year>2011</year>) <article-title>Metadynamics</article-title>. <source>WIREs Comput. Mol. Sci</source>., <volume>1</volume>, <fpage>826</fpage>–<lpage>843</lpage>.</mixed-citation>
    </ref>
    <ref id="btac680-B2">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Bhardwaj</surname><given-names>N.</given-names></string-name></person-group><etal>et al</etal> (<year>2006</year>) <article-title>Structural bioinformatics prediction of membrane-binding proteins</article-title>. <source>J. Mol. Biol</source>., <volume>359</volume>, <fpage>486</fpage>–<lpage>495</lpage>.<pub-id pub-id-type="pmid">16626739</pub-id></mixed-citation>
    </ref>
    <ref id="btac680-B3">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Boes</surname><given-names>D.M.</given-names></string-name></person-group><etal>et al</etal> (<year>2021</year>) <article-title>Peripheral membrane proteins: promising therapeutic targets across domains of life</article-title>. <source>Membranes</source>, <volume>11</volume>, <fpage>346</fpage>.<pub-id pub-id-type="pmid">34066904</pub-id></mixed-citation>
    </ref>
    <ref id="btac680-B4">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Chatzigoulas</surname><given-names>A.</given-names></string-name>, <string-name><surname>Cournia</surname><given-names>Z.</given-names></string-name></person-group> (<year>2021</year>) <article-title>Rational design of allosteric modulators: challenges and successes</article-title>. <source>WIREs Comput. Mol. Sci</source>., <volume>11</volume>, <fpage>e1529</fpage>.</mixed-citation>
    </ref>
    <ref id="btac680-B5">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Chatzigoulas</surname><given-names>A.</given-names></string-name>, <string-name><surname>Cournia</surname><given-names>Z.</given-names></string-name></person-group> (<year>2022</year>) <article-title>Predicting protein–membrane interfaces of peripheral membrane proteins using ensemble machine learning</article-title>. <source>Brief. Bioinformatics</source>, <volume>23</volume>, <fpage>bbab518</fpage>.<pub-id pub-id-type="pmid">35152294</pub-id></mixed-citation>
    </ref>
    <ref id="btac680-B6">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Chen</surname><given-names>L.</given-names></string-name></person-group><etal>et al</etal> (<year>2015</year>) <article-title>Novel inhibitors induce large conformational changes of GAB1 pleckstrin homology domain and kill breast cancer cells</article-title>. <source>PLoS Comput. Biol</source>., <volume>11</volume>, <fpage>e1004021</fpage>.<pub-id pub-id-type="pmid">25569504</pub-id></mixed-citation>
    </ref>
    <ref id="btac680-B244716">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Chung</surname>,<given-names>L.H.</given-names></string-name></person-group><etal>et al</etal> (<year>2021</year>) <article-title>Ceramide transfer protein (CERT): An overlooked molecular player in cancer</article-title>. <source>Int. J. Mol. Sci. </source>, <volume>22</volume>, <fpage>13184</fpage>.<pub-id pub-id-type="pmid">34947980</pub-id></mixed-citation>
    </ref>
    <ref id="btac680-B8">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Cournia</surname><given-names>Z.</given-names></string-name>, <string-name><surname>Chatzigoulas</surname><given-names>A.</given-names></string-name></person-group> (<year>2020</year>) <article-title>Allostery in membrane proteins</article-title>. <source>Curr. Opin. Struct. Biol</source>., <volume>62</volume>, <fpage>197</fpage>–<lpage>204</lpage>.<pub-id pub-id-type="pmid">32446013</pub-id></mixed-citation>
    </ref>
    <ref id="btac680-B9">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Doerr</surname><given-names>S.</given-names></string-name></person-group><etal>et al</etal> (<year>2016</year>) <article-title>HTMD: high-throughput molecular dynamics for molecular discovery</article-title>. <source>J. Chem. Theory Comput</source>., <volume>12</volume>, <fpage>1845</fpage>–<lpage>1852</lpage>.<pub-id pub-id-type="pmid">26949976</pub-id></mixed-citation>
    </ref>
    <ref id="btac680-B10">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Fuglebakk</surname><given-names>E.</given-names></string-name>, <string-name><surname>Reuter</surname><given-names>N.</given-names></string-name></person-group> (<year>2018</year>) <article-title>A model for hydrophobic protrusions on peripheral membrane proteins</article-title>. <source>PLoS Comput. Biol</source>., <volume>14</volume>, <fpage>e1006325</fpage>.<pub-id pub-id-type="pmid">30048443</pub-id></mixed-citation>
    </ref>
    <ref id="btac680-B11">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Greener</surname><given-names>J.G.</given-names></string-name></person-group><etal>et al</etal> (<year>2017</year>) <article-title>Predicting protein dynamics and allostery using multi-protein atomic distance constraints</article-title>. <source>Structure</source>, <volume>25</volume>, <fpage>546</fpage>–<lpage>558</lpage>.<pub-id pub-id-type="pmid">28190781</pub-id></mixed-citation>
    </ref>
    <ref id="btac680-B12">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Gullett</surname><given-names>J.M.</given-names></string-name></person-group><etal>et al</etal> (<year>2022</year>) <article-title>Identification of structural transitions in bacterial fatty acid binding proteins that permit ligand entry and exit at membranes</article-title>. <source>J. Biol. Chem</source>., <volume>298</volume>, <fpage>101676</fpage>.<pub-id pub-id-type="pmid">35122790</pub-id></mixed-citation>
    </ref>
    <ref id="btac680-B13">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Hanson</surname><given-names>R.M.</given-names></string-name></person-group><etal>et al</etal> (<year>2013</year>) <article-title>JSmol and the next-generation web-based representation of 3D molecular structure as applied to proteopedia</article-title>. <source>Isr. J. Chem</source>., <volume>53</volume>, <fpage>207</fpage>–<lpage>216</lpage>.</mixed-citation>
    </ref>
    <ref id="btac680-B50982314">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Jiang</surname>,<given-names>X.</given-names></string-name></person-group><etal>et al</etal> (<year>2022</year>) <article-title>The N-terminal α-helix of potato virus X-encoded RNA-dependent RNA polymerase is required for membrane association and multimerization</article-title>. <source>Viruses</source>, <volume>14</volume>, <fpage>1907</fpage>.<pub-id pub-id-type="pmid">36146714</pub-id></mixed-citation>
    </ref>
    <ref id="btac680-B14">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Jumper</surname><given-names>J.</given-names></string-name></person-group><etal>et al</etal> (<year>2021</year>) <article-title>Highly accurate protein structure prediction with AlphaFold</article-title>. <source>Nature</source>, <volume>596</volume>, <fpage>583</fpage>–<lpage>589</lpage>.<pub-id pub-id-type="pmid">34265844</pub-id></mixed-citation>
    </ref>
    <ref id="btac680-B19306998">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Kaynak</surname>,<given-names>B.T.</given-names></string-name></person-group><etal>et al</etal> (<year>2020</year>) <article-title>Essential site scanning analysis: A new approach for detecting sites that modulate the dispersion of protein global motions</article-title>. <source>Computat. Struct. Biotechnol. J</source>., <volume>18</volume>, <fpage>1577</fpage>–<lpage>1586</lpage>.</mixed-citation>
    </ref>
    <ref id="btac680-B15">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Krivák</surname><given-names>R.</given-names></string-name>, <string-name><surname>Hoksza</surname><given-names>D.</given-names></string-name></person-group> (<year>2018</year>) <article-title>P2Rank: machine learning based tool for rapid and accurate prediction of ligand binding sites from protein structure</article-title>. <source>J. Cheminform</source>., <volume>10</volume>, <fpage>39</fpage>.<pub-id pub-id-type="pmid">30109435</pub-id></mixed-citation>
    </ref>
    <ref id="btac680-B16">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Kufareva</surname><given-names>I.</given-names></string-name></person-group><etal>et al</etal> (<year>2014</year>) <article-title>Discovery of novel membrane binding structures and functions</article-title>. <source>Biochem. Cell Biol.</source>, <volume>92</volume>, <fpage>555</fpage>–<lpage>563</lpage>.<pub-id pub-id-type="pmid">25394204</pub-id></mixed-citation>
    </ref>
    <ref id="btac680-B17">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Li</surname><given-names>Z.</given-names></string-name>, <string-name><surname>Buck</surname><given-names>M.</given-names></string-name></person-group> (<year>2020</year>) <article-title>Computational design of myristoylated cell-penetrating peptides targeting oncogenic K-Ras.G12D at the effector-binding membrane interface</article-title>. <source>J. Chem. Inf. Model</source>., <volume>60</volume>, <fpage>306</fpage>–<lpage>315</lpage>.<pub-id pub-id-type="pmid">31855604</pub-id></mixed-citation>
    </ref>
    <ref id="btac680-B18">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Liu</surname><given-names>Z.</given-names></string-name></person-group><etal>et al</etal> (<year>2010</year>) <article-title>Trp<sup>2313</sup>-His<sup>2315</sup> of factor VIII C2 domain is involved in membrane binding: structure of a complex between the C2 domain and an inhibitor of membrane binding</article-title>. <source>J. Biol. Chem</source>, <volume>285</volume>, <fpage>8824</fpage>–<lpage>8829</lpage>.<pub-id pub-id-type="pmid">20089867</pub-id></mixed-citation>
    </ref>
    <ref id="btac680-B19">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Lloyd</surname><given-names>S.</given-names></string-name></person-group> (<year>1982</year>) <article-title>Least squares quantization in PCM</article-title>. <source>IEEE Trans. Inform. Theory</source>, <volume>28</volume>, <fpage>129</fpage>–<lpage>137</lpage>.</mixed-citation>
    </ref>
    <ref id="btac680-B20">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Lomize</surname><given-names>M.A.</given-names></string-name></person-group><etal>et al</etal> (<year>2012</year>) <article-title>OPM database and PPM web server: resources for positioning of proteins in membranes</article-title>. <source>Nucleic Acids Res</source>., <volume>40</volume>, <fpage>D370</fpage>–D<lpage>376</lpage>.<pub-id pub-id-type="pmid">21890895</pub-id></mixed-citation>
    </ref>
    <ref id="btac680-B21">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Nastou</surname><given-names>K.C.</given-names></string-name></person-group><etal>et al</etal> (<year>2016</year>) <article-title>MBPpred: proteome-wide detection of membrane lipid-binding proteins using profile hidden Markov models</article-title>. <source>Biochim. Biophys. Acta – Proteins Proteom.</source>, <volume>1864</volume>, <fpage>747</fpage>–<lpage>754</lpage>.</mixed-citation>
    </ref>
    <ref id="btac680-B22">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Nawrotek</surname><given-names>A.</given-names></string-name></person-group><etal>et al</etal> (<year>2019</year>) <article-title>PH-domain-binding inhibitors of nucleotide exchange factor BRAG2 disrupt Arf GTPase signaling</article-title>. <source>Nat. Chem. Biol</source>., <volume>15</volume>, <fpage>358</fpage>–<lpage>366</lpage>.<pub-id pub-id-type="pmid">30742123</pub-id></mixed-citation>
    </ref>
    <ref id="btac680-B23">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Nicolaes</surname><given-names>G.A.F.</given-names></string-name></person-group><etal>et al</etal> (<year>2014</year>) <article-title>Rational design of small molecules targeting the C2 domain of coagulation factor VIII</article-title>. <source>Blood</source>, <volume>123</volume>, <fpage>113</fpage>–<lpage>120</lpage>.<pub-id pub-id-type="pmid">24227818</pub-id></mixed-citation>
    </ref>
    <ref id="btac680-B24">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Pedregosa</surname><given-names>F.</given-names></string-name></person-group><etal>et al</etal> (<year>2011</year>) <article-title>Scikit-learn: machine learning in Python</article-title>. <source>J. Mach. Learn. Res</source>., <volume>12</volume>, <fpage>2825</fpage>–<lpage>2830</lpage>.</mixed-citation>
    </ref>
    <ref id="btac680-B54065586">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Remmert</surname>,<given-names>M.</given-names></string-name></person-group><etal>et al</etal> (<year>2012</year>) <article-title>HHblits: lightning-fast iterative protein sequence searching by HMM-HMM alignment</article-title>. <source>Nat. Methods </source>, <volume>9</volume>, <fpage>173</fpage>–<lpage>175</lpage>.</mixed-citation>
    </ref>
    <ref id="btac680-B25">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Rousseeuw</surname><given-names>P.J.</given-names></string-name></person-group> (<year>1987</year>) <article-title>Silhouettes: a graphical aid to the interpretation and validation of cluster analysis</article-title>. <source>J. Comput. Appl. Math</source>., <volume>20</volume>, <fpage>53</fpage>–<lpage>65</lpage>.</mixed-citation>
    </ref>
    <ref id="btac680-B26">
      <mixed-citation publication-type="other"><person-group person-group-type="author"><string-name><surname>Schrödinger</surname><given-names>L.L.C.</given-names></string-name></person-group> The PyMOL Molecular Graphics System, Version 2.0 In.; <year>2015</year>.</mixed-citation>
    </ref>
    <ref id="btac680-B27">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Scott</surname><given-names>D.L.</given-names></string-name></person-group><etal>et al</etal> (<year>2006</year>) <article-title>Protein-lipid interactions: correlation of a predictive algorithm for lipid-binding sites with three-dimensional structural data</article-title>. <source>Theor. Biol. Med. Model</source>., <volume>3</volume>, <fpage>17</fpage>.<pub-id pub-id-type="pmid">16569237</pub-id></mixed-citation>
    </ref>
    <ref id="btac680-B28">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Segers</surname><given-names>K.</given-names></string-name></person-group><etal>et al</etal> (<year>2007</year>) <article-title>Design of protein–membrane interaction inhibitors by virtual ligand screening, proof of concept with the C2 domain of factor V</article-title>. <source>Proc. Natl. Acad. Sci. USA</source>, <volume>104</volume>, <fpage>12697</fpage>–<lpage>12702</lpage>.<pub-id pub-id-type="pmid">17646652</pub-id></mixed-citation>
    </ref>
    <ref id="btac680-B29">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Sharikov</surname><given-names>Y.</given-names></string-name></person-group><etal>et al</etal> (<year>2008</year>) <article-title>MAPAS: a tool for predicting membrane-contacting protein surfaces</article-title>. <source>Nat. Methods</source>, <volume>5</volume>, <fpage>119</fpage>.<pub-id pub-id-type="pmid">18235431</pub-id></mixed-citation>
    </ref>
    <ref id="btac680-B30">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Spiegel</surname><given-names>P.C.</given-names></string-name></person-group><etal>et al</etal> (<year>2004</year>) <article-title>Disruption of protein-membrane binding and identification of small-molecule inhibitors of coagulation factor VIII</article-title>. <source>Chem. Biol</source>., <volume>11</volume>, <fpage>1413</fpage>–<lpage>1422</lpage>.<pub-id pub-id-type="pmid">15489168</pub-id></mixed-citation>
    </ref>
    <ref id="btac680-B31">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Sugiki</surname><given-names>T.</given-names></string-name></person-group><etal>et al</etal> (<year>2012</year>) <article-title>Structural basis for the Golgi association by the pleckstrin homology domain of the ceramide trafficking protein (CERT)</article-title>. <source>J. Biol. Chem</source>., <volume>287</volume>, <fpage>33706</fpage>–<lpage>33718</lpage>.<pub-id pub-id-type="pmid">22869376</pub-id></mixed-citation>
    </ref>
    <ref id="btac680-B6534996">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Valenstein</surname>,<given-names>M.L.</given-names></string-name></person-group><etal>et al</etal> (<year>2022</year>) <article-title>Structure of the nutrient-sensing hub GATOR2</article-title>. <source>Nature</source>, <volume>607</volume>, <fpage>610</fpage>–<lpage>616</lpage>.<pub-id pub-id-type="pmid">35831510</pub-id></mixed-citation>
    </ref>
  </ref-list>
</back>
